Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

MLA

Adnan-Awad, Shady, et al. “Characterization of P190-Bcr-Abl Chronic Myeloid Leukemia Reveals Specific Signaling Pathways and Therapeutic Targets.” Leukemia, vol. 35, no. 7, July 2021, pp. 1964–75. EBSCOhost, https://doi.org/10.1038/s41375-020-01082-4.

APA

Adnan-Awad, S., Kim, D., Hohtari, H., Javarappa, K. K., Brandstoetter, T., Mayer, I., Potdar, S., Heckman, C. A., Kytölä, S., Porkka, K., Doma, E., Sexl, V., Kankainen, M., & Mustjoki, S. (2021). Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets. Leukemia, 35(7), 1964–1975. https://doi.org/10.1038/s41375-020-01082-4

Chicago

Adnan-Awad, Shady, Daehong Kim, Helena Hohtari, Komal Kumar Javarappa, Tania Brandstoetter, Isabella Mayer, Swapnil Potdar, et al. 2021. “Characterization of P190-Bcr-Abl Chronic Myeloid Leukemia Reveals Specific Signaling Pathways and Therapeutic Targets.” Leukemia 35 (7): 1964–75. doi:10.1038/s41375-020-01082-4.